Streamline Health Solutions INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
MDaudit has completed its acquisition of Streamline Health Solutions, Inc., converting each share into $5.34 cash and taking the company private.
Streamline Health Solutions, Inc. stockholders overwhelmingly approved the merger agreement with Mist Holding Co. and an advisory vote on executive compensation related to the transaction.
Streamline Health Solutions, Inc. and its subsidiaries have entered into a seventh modification of their loan agreement with Western Alliance Bank, adjusting financial covenants and securing a temporary increase in their revolving credit line, while also approving executive transaction bonuses related to an upcoming merger.
Streamline Health Solutions, Inc. announced improved fiscal first quarter 2025 financial results and a definitive all-cash merger agreement to be acquired by MDaudit for approximately $37.4 million, representing a substantial premium for shareholders.
MDaudit has entered into a definitive merger agreement to acquire Streamline Health Solutions, Inc. for $5.34 per share in cash, representing a substantial premium for Streamline shareholders and aiming to create a unified healthcare revenue cycle platform.
Streamline Health Solutions reports a decrease in total revenue for fiscal year 2024 but aims for adjusted EBITDA positive run rate in the first half of fiscal 2025.
Streamline Health Solutions modifies its loan agreement with Western Alliance Bank, waiving certain defaults and adjusting financial covenants to improve financial flexibility.
Streamline Health reported a reduced net loss and accelerated its timeline for achieving adjusted EBITDA breakeven, despite a decrease in overall revenue.
8-K: Streamline Health Amends Loan Agreement with Western Alliance Bank, Modifies Financial Covenants
Streamline Health Solutions has modified its loan agreement with Western Alliance Bank, adjusting financial covenants and incurring fees in the process.
Streamline Health Solutions, Inc. will implement a 1-for-15 reverse stock split effective October 4, 2024, to comply with Nasdaq's minimum bid price requirement.
Streamline Health Solutions' stockholders approved a reverse stock split proposal and a proposal to adjourn the special meeting if needed to gather more votes.
Streamline Health reported a net loss for the second quarter of fiscal 2024, but showed improvement in adjusted EBITDA and reiterated its SaaS ARR breakeven target, albeit with a revised timeline.
Streamline Health Solutions' stockholders approved a new omnibus incentive compensation plan and elected seven directors at their 2024 annual meeting.
Streamline Health Solutions reported a reduced net loss and improved adjusted EBITDA for the first quarter of fiscal 2024, while reiterating its target for adjusted EBITDA breakeven run rate.
Streamline Health Solutions has amended its employment agreement with Executive Chairman Wyche T. Tee Green, III, adjusting his base salary, bonus, and equity incentives.
Streamline Health announced its fiscal 2023 fourth quarter and full year results, highlighted by SaaS revenue growth and improved adjusted EBITDA, while also receiving an extension to regain compliance with Nasdaq's minimum bid price requirement.
Streamline Health Solutions, Inc. announced a $4.5 million private placement, the appointment of two new board members, and modifications to its existing credit facility.